Yongxing Bao

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Neoadjuvant Chemotherapy

Locally Advanced

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Zeliang Ma, Bin Liang, Ran Wei, Yunsong Liu, Yongxing Bao, Meng Yuan, Yu Men, Jianyang Wang, Lei Deng, Yirui Zhai, Nan Bi, Luhua Wang, Jianrong Dai, Zhouguang Hui
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial. Thoracic cancer (2023)
Yongxing Bao, Yang Wang, Zhouguang Hui
Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer. Thoracic cancer 13 (21) (2022)
Meng Yuan, Yirui Zhai, Yu Men, Maoyuan Zhao, Xin Sun, Zeliang Ma, Xu Yang, Shuang Sun, Yongxing Bao, Yunsong Liu, Zhouguang Hui
Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer. Thoracic cancer 13 (23) (2022)
Yongxing Bao, Zeliang Ma, Meng Yuan, Yang Wang, Yu Men, Zhouguang Hui
Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta-analysis. Thoracic cancer 13 (17) (2022)
Yongxing Bao, Xu Yang, Yu Men, Jingjing Kang, Xin Sun, Maoyuan Zhao, Shuang Sun, Meng Yuan, Zeliang Ma, Zhouguang Hui
Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database. Thoracic cancer 13 (3) (2021)